The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome

D
David Haas, MD

Primary Investigator

J
Jessica MacLean

Primary Investigator

Overview

The purpose of this study is to see if a hormone in your blood can tell us how if your baby is responding to the shots of betamethasone that you are receiving. Other studies have shown that it may be able to do this.

Description

The objective of this study is to duplicate Torday?s original results in a diverse patient population at IUSM affiliated facilities.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Neonatal Respiratory Distress Syndrome
  • Age: Between 18 Years - 100 Years
  • Gender: Female
Updated on 25 Apr 2024. Study ID: 1108006470

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center